WuXi AppTec
Mainland China · SHA:603259
Market Cap35B
Revenue6.5B
Employees45000
Founded2000
TickerSHA:603259
CEO / ExecGe Li
HeadquartersShanghai
MarketMainland China
Overview
WuXi AppTec is a leading Chinese contract research organization (CRO) providing R&D and manufacturing services for the global pharmaceutical industry. It holds a top-tier market position as one of the world's largest CROs by revenue, notably operating an integrated end-to-end platform from drug discovery to commercial production.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.
Related Listings
Key Facts
- Drug discovery and development services
- Contract research and manufacturing (CRDMO)
- Cell and gene therapy services
Detailed Description
WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company, providing R&D and manufacturing services across the drug development value chain. Headquartered in Shanghai, it serves over 6,000 customers worldwide, including top pharmaceutical and biotech firms, and is a key player in China's life sciences outsourcing industry.